The Dangerous “Science” of Gregory Clark, as Read in <i>The New York Times</i>
By Matt Ruben,
Philadelphia Magazine
| 02. 26. 2014
Earlier this week, Sandy Hingston reported on a new study by California economics professor Gregory Clark, which claims genes, not social factors, are why it’s so hard to move up the socio-economic ladder these days. Intrigued, I read Clark’s own recent New York Times column explaining his work, and a shiver ran down my spine.
Every year, I teach a course at Bryn Mawr College that examines poverty and social mobility throughout history. And every year, my students are shocked by a 19th Century Englishman named Francis Galton.
Galton founded the pseudo-science of Eugenics. He used a bastardized version of his cousin Charles Darwin’s theory of Natural Selection to argue what Clark argues: that genetics explains why elite families and groups remain on top from generation to generation, while the rest of us have a tougher time.
Galton, whose work was highly influential in Europe and America, noticed that the same last names kept appearing in lists of award-winners at his alma mater of Cambridge. Similarly, Clark and his colleagues found that centuries-old elite surnames continue to show up...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Antonio Regalado, MIT Technology Review | 06.05.2025
Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on gene-editing human embryos. If he goes forward, it would be the first major commercial investment in one of medicine’s most...